Abstract. This study was designed to test the hypothesis that a triggered release of a topical microbicide (tenofovir) from hyaluronic acid nanoparticles (HA-NPs) can be achieved under the influence of hyaluronidase (HAase) enzyme. A fractional factorial experimental design was used to examine the factors [molar concentrations of adipic acid dihydrazide (X 1 ) and 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (X 2 ), volume of acetone (X 3 ) and reaction time (X 4 )] influencing the responses, Y 1 ; particle mean diameter: PMD (nanometers: nm), Y 2 ; polydispersity index: PDI and Y 3 ; zeta (ζ) potential: (millivolts). The amide bond formation between HA and ADH after cross-linking was confirmed by FT-IR and 13 C-NMR analyses. These NPs were also characterized for cytotoxicity on a human vaginal epithelial cell line and L. crispatus. When formulated with factors X 1 ; 2.49 mM, X 2 ; 9.96 mM, X 3 ; 60 mL, X 4 ; 6 h, HA-NPs exhibited a spherical shape with PMD, PDI, ζ potential, encapsulation efficiency, and drug loading of 70.6±4.1 nm, 0.07±0.02, −38.2±2.8 mV, 51.8±2.4% w/w and 26.1±1.2% w/w, respectively, (n=3). Unlike for HA based gel, HAase significantly triggered the drug release and HA degradation from the NPs after 24 h (∼90% w/w and 65% w/w, respectively); whereas, in its absence, these values were ∼39% w/w and 26% w/w, respectively. The NPs were non-cytotoxic to human vaginal VK2/ E6E7, End1/E6E7 cells and Lactobacillus crispatus. These data highlight the potential of HAase-sensitive HA-NPs templates for the controlled and vaginal delivery of anti-HIV/AIDS microbicides.